欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/1541/001
药品名称
FERANT
活性成分
Palonosetron hydrochloride 250.0 µg
剂型
Solution for injection
上市许可持有人
Medochemie Ltd, Cyprus
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Greece (GR)
FERANT
Latvia (LV)
Ferant 250 mikrogrami šķīdums injekcijām
Lithuania (LT)
FERANT 250 mikrogramų injekcinis tirpalas
Estonia (EE)
FERANT
Bulgaria (BG)
Ferant
Cyprus (CY)
Czechia (CZ)
FERANT 250 MIKROGRAMŮ INJEKČNÍ ROZTOK
Romania (RO)
Slovakia (SK)
FERANT 250 mikrogramov injekčný roztok
Malta (MT)
Croatia (HR)
Ferant 250 mikrograma otopina za injekciju
Spain (ES)
Portugal (PT)
Slovenia (SI)
许可日期
2016/04/20
最近更新日期
2024/12/11
药物ATC编码
A04AA05 palonosetron
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
SE_H_1541_001_Final PL
Date of last change:2024/09/06
Final SPC
|
SE_H_1541_001_Final SPC
Date of last change:2024/09/06
PubAR
|
SE_H_1541_001_PAR
Date of last change:2024/09/06
PubAR Summary
|
SE_H_1541_001_PAR Summary
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase